Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Market Cap	30.51M
Revenue (ttm)	n/a
Net Income (ttm)	-2.20M
Shares Out	160.55M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	271,500
Average Volume	124,450
Open	0.1600
Previous Close	0.1900
Day's Range	0.1600 - 0.1700
52-Week Range	0.0400 - 0.2450
Beta	0.79
RSI	46.09
Earnings Date	Apr 25, 2025

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Brent Willis
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VM